InsiderTrades

Form 4 for THC TENET HEALTHCARE CORP

Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001193125-26-089408 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-03 2026-02-27 THC Arnst Thomas W EVP, GC, Chief Admin. Off F - Tax $239.26 -20.8K 32.0K -39% -$4.97M
D 2026-03-03 2026-03-02 THC Arnst Thomas W EVP, GC, Chief Admin. Off S - Sale+OE $234.04 -24.0K 8,012 -75% -$5.62M
DM 2026-03-03 2026-02-27 THC Arnst Thomas W EVP, GC, Chief Admin. Off M - OptEx — +11.2K 47.2K +31% —
D 2026-03-03 2026-02-27 THC Arnst Thomas W EVP, GC, Chief Admin. Off A - Grant $0.00 +7,520 7,520 New $0
DM 2026-03-03 2026-02-27 THC Arnst Thomas W EVP, GC, Chief Admin. Off M - OptEx $0.00 -11.2K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-27 F D 1,496 $237.58 51,291 D — — (F2) Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. (F3) Represents the closing price of the common stock of the Issuer on the vesting date for the award.
2 Common Common Stock 2026-02-27 F D 4,409 $239.39 46,882 D — — (F4) Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. (F5) Represents the closing price of the common stock of the Issuer on February 27, 2026.
3 Common Common Stock 2026-02-27 F D 14,870 $239.39 32,012 D — — (F2) Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. (F5) Represents the closing price of the common stock of the Issuer on February 27, 2026.
4 Common Common Stock 2026-03-02 S D 24,000 $234.04 8,012 D — — (F10) The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $234.00 to $234.34. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
5 Common Common Stock 2026-02-27 M A 5,598 — 52,787 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
6 Common Common Stock 2026-02-27 M A 5,604 — 47,189 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
7 Derivative 2026 February Restricted Stock Units 2026-02-27 A A 7,520 $0.00 7,520 D — · — to — 7,520 Common Stock (F6) These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.
8 Derivative 2024 February Restricted Stock Units 2026-02-27 M D 5,604 $0.00 5,605 D — · — to — 5,604 Common Stock (F7) The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).
9 Derivative 2023 March Restricted Stock Units 2026-02-27 M D 5,598 $0.00 0 D — · — to — 5,598 Common Stock (F9) The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).